ArriVent BioPharma, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 11/14/2025 | 4.48 M | $82.74 M | 0.00% | 10.70% |
| INFINITUM ASSET MANAGEMENT, LLC | 11/14/2025 | 3.87 M | $71.38 M | 13.16% | 9.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 3.70 M | $68.33 M | 8.52% | 8.84% |
| FMR LLC | 11/13/2025 | 3.41 M | $62.87 M | 65.57% | 8.13% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 3.03 M | $55.85 M | 0.00% | 7.22% |
| BLACKROCK, INC. | 11/12/2025 | 2.05 M | $37.75 M | 11.30% | 4.88% |
| VANGUARD GROUP INC | 11/07/2025 | 2.03 M | $37.44 M | 36.80% | 4.84% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 1.97 M | $36.37 M | 1.28% | 4.70% |
| NOVO HOLDINGS A/S | 11/14/2025 | 1.94 M | $35.83 M | 3.74% | 4.63% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 1.70 M | $31.31 M | 0.00% | 4.05% |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 11/14/2025 | 1.49 M | $27.58 M | 0.00% | 3.57% |
| STATE STREET CORP | 11/14/2025 | 1.03 M | $18.96 M | 38.72% | 2.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 716.29 K | $13.22 M | 20.18% | 1.71% |
| SIREN, L.L.C. | 11/13/2025 | 700.00 K | $12.92 M | 0.00% | 1.67% |
| SC CHINA HOLDING LTD | 11/14/2025 | 663.31 K | $12.99 M | 0.00% | 1.58% |
| FUND 1 INVESTMENTS, LLC | 11/14/2025 | 619.85 K | $11.44 M | 17.31% | 1.48% |
| UBS GROUP AG | 11/13/2025 | 497.60 K | $9.18 M | 474.68% | 1.19% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 431.94 K | $7.97 M | 27.34% | 1.03% |
| COOPERMAN LEON G | 11/14/2025 | 421.28 K | $7.77 M | 0.00% | 1.01% |
| MORGAN STANLEY | 11/14/2025 | 392.02 K | $7.23 M | 286.78% | 0.94% |
| HIDDEN LAKE ASSET MANAGEMENT LP | 11/14/2025 | 314.04 K | $5.79 M | -48.25% | 0.75% |
| WOODLINE PARTNERS LP | 11/14/2025 | 296.92 K | $5.48 M | 102.10% | 0.71% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 286.10 K | $5.28 M | 62.40% | 0.68% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 256.42 K | $4.73 M | 100.00% | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 243.49 K | $4.49 M | 29.37% | 0.58% |
| NORTHERN TRUST CORP | 11/14/2025 | 231.17 K | $4.27 M | 11.81% | 0.55% |
| MARSHALL WACE, LLP | 11/13/2025 | 180.22 K | $3.33 M | 100.00% | 0.43% |
| BARCLAYS PLC | 11/12/2025 | 129.94 K | $2.40 M | 10.85% | 0.31% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 128.31 K | $2.37 M | -37.21% | 0.31% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 11/14/2025 | 100.00 K | $1.85 M | 100.00% | 0.24% |
| ANSON FUNDS MANAGEMENT LP | 11/14/2025 | 99.89 K | $1.84 M | 100.00% | 0.24% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 91.72 K | $1.69 M | 100.00% | 0.22% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 81.75 K | $1.51 M | 23.24% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 63.28 K | $1.17 M | 7.66% | 0.15% |
| MOODY ALDRICH PARTNERS LLC | 10/21/2025 | 59.45 K | $1.10 M | -16.93% | 0.14% |
| NUVEEN, LLC | 11/12/2025 | 47.66 K | $879.38 K | 0.00% | 0.11% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 45.98 K | $848.28 K | 49.53% | 0.11% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 43.80 K | $808.11 K | 31.53% | 0.10% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 42.27 K | $779.85 K | 1,544.03% | 0.10% |
| QUEST PARTNERS LLC | 11/03/2025 | 41.45 K | $764.73 K | 100.00% | 0.10% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 40.80 K | $752.76 K | 100.00% | 0.10% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2025 | 39.24 K | $723.89 K | 10.27% | 0.09% |
| SG AMERICAS SECURITIES, LLC | 10/23/2025 | 36.94 K | $682.00 K | 34.47% | 0.09% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/14/2025 | 36.14 K | $666.71 K | -24.06% | 0.09% |
| SWISS NATIONAL BANK | 11/13/2025 | 35.50 K | $654.98 K | 34.47% | 0.08% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/12/2025 | 34.36 K | $633.96 K | 118.18% | 0.08% |
| RHUMBLINE ADVISERS | 11/06/2025 | 33.80 K | $623.65 K | -0.44% | 0.08% |
| CI PRIVATE WEALTH, LLC | 11/14/2025 | 33.50 K | $618.08 K | 100.00% | 0.08% |
| CORIENT IA LLC | 11/12/2025 | 33.50 K | $618.08 K | 100.00% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 33.00 K | $608.85 K | 100.00% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ArriVent BioPharma, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 120 institutional investors and hedge funds held shares of ArriVent BioPharma, Inc. Common Stock. The most heavily invested institutionals were:
HHLR ADVISORS, LTD.: 4.48 M
INFINITUM ASSET MANAGEMENT, LLC: 3.87 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 3.7 M
FMR LLC: 3.41 M
ORBIMED ADVISORS LLC: 3.03 M
BlackRock, Inc.: 2.05 M
92.03% of ArriVent BioPharma, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 39.83 M shares in the last 24 months. This purchase volume represents approximately $790.30 M in transactions.